Effect of oral contraceptives on levels of adipokines, and adiposity indices in women with polycystic ovary syndrome
Phase 3
- Conditions
- Reproductive health..
- Registration Number
- IRCT20080929001281N3
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Existence of diagnostic criteria for polycystic ovary syndrome based on Androgen Excess and PCOS Society (AES)
Age range: 18 to 45 years
Exclusion Criteria
Pregnancy
Use of hormonal; anti-androgen or insulin sensitizer drugs for at least 3 months before the study
Detection of severe hypertension; chronic disease; recent surgery or diagnosis of cancer
Smoking
Obesity
Appearing the serious side effects such as thrombosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of adiponectin. Timepoint: baseline, 6th month. Method of measurement: Assessment of this parameter will be done using Human ELISA kites.;Serum levels of leptin. Timepoint: baseline, 6th month. Method of measurement: Assessment of this parameter will be done using Human ELISA kites.;Serum levels of resistin. Timepoint: baseline, 6th month. Method of measurement: Assessment of this parameter will be done using Human ELISA kites.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: Baseline, 6th month. Method of measurement: Sphygmomanometer.